BAXTER HEALTHCARE CORP.

BENDAMUSTINE HYDROCHLORIDE

Manufacturer:

BAXTER HEALTHCARE CORP.

Bendamustine Hydrochloride HCPCS:

J9059

HCPCS Code Descriptor:

Injection, bendamustine hydrochloride (baxter), 1 mg

Category:

J Code

Bendamustine Hydrochloride NDCs:

10019-0079-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Bendamustine Hydrochloride CPT Codes:

Potential CPT administration codes for Bendamustine Hydrochloride can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Bendamustine Hydrochloride:

BENDAMUSTINE HYDROCHLORIDE is a Oncology drug manufactured by BAXTER HEALTHCARE CORP. and administered via the Intravenous route of administration. The J Code: J9059 is aligned to the drug BENDAMUSTINE HYDROCHLORIDE.

ACCESS PRICING AND MORE BY REGISTERING

J9059 Added Date:

July 1, 2023

J9059 Effective Date:

July 1, 2023

J9059 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Bendamustine Hydrochloride billing and coding information.
Our team did not identify a source for Bendamustine Hydrochloride patient assistance information. Please reach out to our team if you feel that this is a mistake.
BENDAMUSTINE HYDROCHLORIDE prescribing information can be found at the link below:
Information regarding BENDAMUSTINE HYDROCHLORIDE’s side effects can be found at MedlinePlus